首页 > 最新文献

Journal of the Turkish German Gynecological Association最新文献

英文 中文
Retrospective evaluation of transvaginal cervical cerclage cases in a tertiary reference center: comparison of indications and suture materials. 回顾性评价经阴道宫颈环扎术病例在三级参考中心:比较适应证和缝合材料。
IF 1.4 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-09-03 Epub Date: 2025-07-31 DOI: 10.4274/jtgga.galenos.2025.2024-11-4
Umutcan Kayıkçı, Erdem Fadıloğlu, Ayşe Çiğdem Bayrak, İlgi Adalı, Edip Alptuğ Kır, Özgür Deren

Objective: To compare history-indicated cervical cerclage (HICC), ultrasound-indicated CC (UICC) and physical examination-indicated CC (PEICC) in terms of obstetric outcomes and to compare the outcomes related to braided and non-braided suture materials (Prolene suture vs. Mersilene tape).

Material and methods: We retrospectively evaluated 173 transvaginal CC procedures performed in a single center. Cases were classified based on procedure indications and the type of suture material used.

Results: Of the 173 cases reviewed, 103 (59.5%), 45 (26.0%) and 25 (14.4%) cases were in the HICC, UICC and PEICC groups, respectively. Patients in the PEICC group underwent cerclage at significantly later gestational weeks, had higher hospitalization rates, longer hospital stays following the procedure, a shorter interval between cerclage and delivery, and a higher rate of procedure-related pregnancy loss compared to the other groups (p<0.05 for all). Both the gestational age at delivery and the take-home baby rate were lower in this group compared to the other groups (p<0.05 for both). There were no significant differences identified in terms of suture materials used. Subgroup analyses revealed similar obstetric outcomes between different suture materials.

Conclusion: PEICC had worse perinatal outcomes compared to HICC and UICC procedures. CC indication was the major determinant of perinatal outcome in this cohort while suture material had no significant effect on perinatal outcomes.

目的:比较历史指示的宫颈环切术(HICC)、超声指示的宫颈环切术(UICC)和体格检查指示的宫颈环切术(PEICC)的产科结局,并比较编织和非编织缝合材料(Prolene缝合与Mersilene胶带)的结局。材料和方法:我们回顾性评估了173例在单一中心进行的经阴道CC手术。根据手术适应证和所用缝合材料的类型对病例进行分类。结果:173例病例中,HICC组103例(59.5%),UICC组45例(26.0%),PEICC组25例(14.4%)。与其他组相比,PEICC组患者接受环切术的妊娠周明显较晚,住院率较高,手术后住院时间较长,环切术与分娩之间的间隔较短,手术相关的妊娠丢失率较高(结论:与HICC和UICC手术相比,PEICC围产儿结局更差)。CC指征是该队列围产儿结局的主要决定因素,而缝合材料对围产儿结局无显著影响。
{"title":"Retrospective evaluation of transvaginal cervical cerclage cases in a tertiary reference center: comparison of indications and suture materials.","authors":"Umutcan Kayıkçı, Erdem Fadıloğlu, Ayşe Çiğdem Bayrak, İlgi Adalı, Edip Alptuğ Kır, Özgür Deren","doi":"10.4274/jtgga.galenos.2025.2024-11-4","DOIUrl":"10.4274/jtgga.galenos.2025.2024-11-4","url":null,"abstract":"<p><strong>Objective: </strong>To compare history-indicated cervical cerclage (HICC), ultrasound-indicated CC (UICC) and physical examination-indicated CC (PEICC) in terms of obstetric outcomes and to compare the outcomes related to braided and non-braided suture materials (Prolene suture vs. Mersilene tape).</p><p><strong>Material and methods: </strong>We retrospectively evaluated 173 transvaginal CC procedures performed in a single center. Cases were classified based on procedure indications and the type of suture material used.</p><p><strong>Results: </strong>Of the 173 cases reviewed, 103 (59.5%), 45 (26.0%) and 25 (14.4%) cases were in the HICC, UICC and PEICC groups, respectively. Patients in the PEICC group underwent cerclage at significantly later gestational weeks, had higher hospitalization rates, longer hospital stays following the procedure, a shorter interval between cerclage and delivery, and a higher rate of procedure-related pregnancy loss compared to the other groups (p<0.05 for all). Both the gestational age at delivery and the take-home baby rate were lower in this group compared to the other groups (p<0.05 for both). There were no significant differences identified in terms of suture materials used. Subgroup analyses revealed similar obstetric outcomes between different suture materials.</p><p><strong>Conclusion: </strong>PEICC had worse perinatal outcomes compared to HICC and UICC procedures. CC indication was the major determinant of perinatal outcome in this cohort while suture material had no significant effect on perinatal outcomes.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":" ","pages":"180-189"},"PeriodicalIF":1.4,"publicationDate":"2025-09-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12406971/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144753657","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Determining the optimal follow-up protocol after primary surgery in patients with early-stage endometrial cancer. 确定早期子宫内膜癌患者初次手术后的最佳随访方案。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2025-2-4
Can Ozan Ulusoy, Bulut Varlı, Ali Gökçe, Duygu Altın, Şahin Kaan Baydemir, Uğur Fırat Ortaç, Salih Taşkın

Objective: The aim of this study was to investigate the timing of recurrence in patients with early-stage endometrial cancer and to determine the optimal postoperative follow-up protocol for the detection of recurrence.

Material and methods: Patients with stage 1 and 2, grade 1-3 endometrioid type endometrial cancer who underwent follow-up for at least two years were included. The diagnostic method for recurrence was analyzed for each patient. Analysis of risk factors for recurrence were done using SPSS. Sensitivity analyzes were performed comparing the diagnostic methods.

Results: A total of 303 patients were included and recurrence was diagnosed in 17 (5.61%). Cumulative risk of recurrence was 3.06% in the first 23 months, rising to 7.52% in the first 33 months. Sensitivity of physical examination (PE) was 50.00%, specificity 99.52%, positive predictive value 88.89%, negative predictive value 96.30% and accuracy rate 96.00% respectively. It was found that each step increase of grade increased recurrence odds by 2.549 times [95% confidence interval (CI): 1.078-6.027; p=0.033] while each step increase of stage increased recurrence odds by 2.943 times (95% CI: 1.270-6.820; p=0.012).

Conclusion: It is notable that recurrence rate increased after 25 months and the risk of recurrence increased as the tumor stage and grade worsened. Symptoms in patients with high-grade and deep myometrial invasion, especially after the first two years, should be considered risky and patients should be informed about seeking medical care when symptoms occur. PE and symptoms of patients are key factors in detecting reccurence while other diagnostic methods can be used according to clinical findings.

目的:本研究的目的是探讨早期子宫内膜癌患者的复发时间,并确定最佳的术后随访方案,以发现复发。材料和方法:纳入随访至少2年的1期和2期、1-3级子宫内膜样型子宫内膜癌患者。分析每位患者复发的诊断方法。采用SPSS软件对复发危险因素进行分析。对不同诊断方法进行敏感性分析。结果:共纳入303例患者,其中17例(5.61%)确诊复发。前23个月累计复发风险为3.06%,前33个月上升至7.52%。体格检查(PE)敏感性为50.00%,特异性为99.52%,阳性预测值为88.89%,阴性预测值为96.30%,准确率为96.00%。结果发现,分级每增加一级,复发几率增加2.549倍[95%可信区间(CI): 1.078 ~ 6.027;p=0.033]而分期每增加一步,复发几率增加2.943倍(95% CI: 1.270 ~ 6.820;p = 0.012)。结论:随着肿瘤分期和分级的加重,25个月后复发率增加,复发风险增加。高度和深度肌层浸润患者的症状,特别是在头两年之后,应被认为是危险的,当出现症状时应告知患者寻求医疗护理。PE和患者的症状是诊断复发的关键因素,其他诊断方法可根据临床表现选择。
{"title":"Determining the optimal follow-up protocol after primary surgery in patients with early-stage endometrial cancer.","authors":"Can Ozan Ulusoy, Bulut Varlı, Ali Gökçe, Duygu Altın, Şahin Kaan Baydemir, Uğur Fırat Ortaç, Salih Taşkın","doi":"10.4274/jtgga.galenos.2025.2025-2-4","DOIUrl":"10.4274/jtgga.galenos.2025.2025-2-4","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to investigate the timing of recurrence in patients with early-stage endometrial cancer and to determine the optimal postoperative follow-up protocol for the detection of recurrence.</p><p><strong>Material and methods: </strong>Patients with stage 1 and 2, grade 1-3 endometrioid type endometrial cancer who underwent follow-up for at least two years were included. The diagnostic method for recurrence was analyzed for each patient. Analysis of risk factors for recurrence were done using SPSS. Sensitivity analyzes were performed comparing the diagnostic methods.</p><p><strong>Results: </strong>A total of 303 patients were included and recurrence was diagnosed in 17 (5.61%). Cumulative risk of recurrence was 3.06% in the first 23 months, rising to 7.52% in the first 33 months. Sensitivity of physical examination (PE) was 50.00%, specificity 99.52%, positive predictive value 88.89%, negative predictive value 96.30% and accuracy rate 96.00% respectively. It was found that each step increase of grade increased recurrence odds by 2.549 times [95% confidence interval (CI): 1.078-6.027; p=0.033] while each step increase of stage increased recurrence odds by 2.943 times (95% CI: 1.270-6.820; p=0.012).</p><p><strong>Conclusion: </strong>It is notable that recurrence rate increased after 25 months and the risk of recurrence increased as the tumor stage and grade worsened. Symptoms in patients with high-grade and deep myometrial invasion, especially after the first two years, should be considered risky and patients should be informed about seeking medical care when symptoms occur. PE and symptoms of patients are key factors in detecting reccurence while other diagnostic methods can be used according to clinical findings.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"82-89"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152776/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266475","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The effect of COVID-19 (SARS-CoV-2) vaccines on vulvar condylomata. COVID-19 (SARS-CoV-2)疫苗对外阴尖锐湿疣的影响。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2025-4-8
Mustafa Şahin, Şeyma Banu Arslanca

Objective: Current evidence concerning the possible clinical effects of coronavirus disease-2019 (COVID-19) vaccines on vulvar lesions is limited. The aim was to describe the effect of vaccines against COVID-19 on the progression of vulvar condylomas.

Material and methods: The data of patients diagnosed with condylomata acuminate and treated with trichloroacetic acid (TCA) between January 2021 and January 2023 in the gynecological oncology surgery clinic were evaluated. The patients were divided into groups based on their vaccination status; vaccinated or unvaccinated. The number/area of condylomas and symptom degrees of the patients before and after TCA treatment were compared.

Results: A total of 202 patients, 102 vaccinated and 100 unvaccinated, were included. There was no significant difference between the groups in terms of age, parity, smoking, oral contraceptive use, amount of condyloma and symptom degree (all p>0.05). There was no significant difference in the amount of condyloma between the groups after six months [p=0.589, 95% confidence interval (CI)=0.238-1.566]. Moreover, there was no difference in the degree of symptoms after six months between the groups (p=0.467, 95% CI=1.113-1.799).

Conclusion: The systemic effects caused by COVID-19 vaccines are still not fully understood. Considering that this vaccine, like many vaccines, elicits a strong immunogenic reaction, the possible clinical impact of this non-specific systemic inflammatory response on vulvar condyloma is a matter of curiosity. This study showed there was no difference in the amount of condyloma and the degree of symptoms six months after TCA treatment in the unvaccinated and vaccinated group. The low number of patients is the biggest limitation of this study. Larger studies may provide more robust information.

目的:目前关于2019冠状病毒病(COVID-19)疫苗对外阴病变可能的临床效果的证据有限。目的是描述COVID-19疫苗对外阴尖锐湿疣进展的影响。材料与方法:对2021年1月至2023年1月在妇科肿瘤外科门诊诊断为尖锐湿疣并使用三氯乙酸(TCA)治疗的患者资料进行评价。根据疫苗接种情况将患者分组;接种或未接种。比较TCA治疗前后患者尖锐湿疣的数量/面积及症状程度。结果:共纳入202例患者,其中接种者102例,未接种者100例。年龄、胎次、吸烟情况、口服避孕药使用情况、尖锐湿疣数量、症状程度组间比较差异均无统计学意义(p < 0.05)。6个月后,两组间尖锐湿疣数量差异无统计学意义[p=0.589, 95%可信区间(CI)=0.238 ~ 1.566]。此外,6个月后两组患者的症状程度无差异(p=0.467, 95% CI=1.113-1.799)。结论:COVID-19疫苗引起的全身效应尚不完全清楚。考虑到这种疫苗,像许多疫苗一样,引起强烈的免疫原性反应,这种非特异性全身炎症反应对外阴尖锐湿疣可能的临床影响是一个好奇的问题。这项研究表明,未接种疫苗组和接种疫苗组在TCA治疗6个月后,尖锐湿疣的数量和症状程度没有差异。患者数量少是本研究的最大限制。更大规模的研究可能会提供更可靠的信息。
{"title":"The effect of COVID-19 (SARS-CoV-2) vaccines on vulvar condylomata.","authors":"Mustafa Şahin, Şeyma Banu Arslanca","doi":"10.4274/jtgga.galenos.2025.2025-4-8","DOIUrl":"10.4274/jtgga.galenos.2025.2025-4-8","url":null,"abstract":"<p><strong>Objective: </strong>Current evidence concerning the possible clinical effects of coronavirus disease-2019 (COVID-19) vaccines on vulvar lesions is limited. The aim was to describe the effect of vaccines against COVID-19 on the progression of vulvar condylomas.</p><p><strong>Material and methods: </strong>The data of patients diagnosed with condylomata acuminate and treated with trichloroacetic acid (TCA) between January 2021 and January 2023 in the gynecological oncology surgery clinic were evaluated. The patients were divided into groups based on their vaccination status; vaccinated or unvaccinated. The number/area of condylomas and symptom degrees of the patients before and after TCA treatment were compared.</p><p><strong>Results: </strong>A total of 202 patients, 102 vaccinated and 100 unvaccinated, were included. There was no significant difference between the groups in terms of age, parity, smoking, oral contraceptive use, amount of condyloma and symptom degree (all p>0.05). There was no significant difference in the amount of condyloma between the groups after six months [p=0.589, 95% confidence interval (CI)=0.238-1.566]. Moreover, there was no difference in the degree of symptoms after six months between the groups (p=0.467, 95% CI=1.113-1.799).</p><p><strong>Conclusion: </strong>The systemic effects caused by COVID-19 vaccines are still not fully understood. Considering that this vaccine, like many vaccines, elicits a strong immunogenic reaction, the possible clinical impact of this non-specific systemic inflammatory response on vulvar condyloma is a matter of curiosity. This study showed there was no difference in the amount of condyloma and the degree of symptoms six months after TCA treatment in the unvaccinated and vaccinated group. The low number of patients is the biggest limitation of this study. Larger studies may provide more robust information.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"116-120"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152815/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The histologic results in multiple-type HPV infections. 组织学结果为多型HPV感染。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2023-4-2
Sevgi Koç, Dilek Yüksel, Eylem Ünlübilgin, Tuğba Kınay, Fulya Kayıkçıoğlu

Objective: To evaluate the rate, cytology and histopathological findings of multiple-type human papillomavirus (HPV) positive women referred to a tertiary colposcopy center. To compare the role of multiple- and single-type HPV infections in women with high-grade squamous intra epithelial lesion and cervical cancer (HSIL+).

Material and methods: The cytological and histopathological results of 2070 HPV positive women were evaluated. Infection with more than one type was defined as multiple-type HPV infection. Patients were divided into single or multiple HPV groups and subgroups in terms of HPV types; and also examined in three age groups. Age-stratified HSIL and cervical cancer rates of the study groups were compared.

Results: The women with multiple HPV subtypes accounted for 24.9% of the study population. Multiple-type HPV infection rates in normal cytology, atypical glandular cells, low-grade squamous intraepithelial lesion (LSIL), atypical squamous cells, cannot exclude HSIL and HSIL were 28.2%, 26.8%, 19.3%, 22.6%, and 21.8%, respectively. Age stratified multiple-type HPV infection rates in under 30 years, 30-49 years and ≥50 years were 27.8%, 24.1%, and 27.3%, respectively. The multiple-type HPV infection rates in LSIL, HSIL, and cancer patients were 31.4%, 19%, and 12.5%, respectively.

Conclusion: Multiple-type HPV infections were statistically less common in HSIL and cancer patients than single type HPV infection. However, multiple type infection rates were remarkable in older HSIL and cervical cancer patients.

目的:评价某三级阴道镜中心多型人乳头瘤病毒(HPV)阳性妇女的转诊率、细胞学和组织病理学检查结果。比较多型和单型HPV感染在女性高级别鳞状上皮内病变和宫颈癌(HSIL+)中的作用。材料与方法:对2070例HPV阳性妇女的细胞学和组织病理学结果进行评价。超过一种类型的感染被定义为多型HPV感染。根据HPV类型将患者分为单一或多个HPV组和亚组;并对三个年龄组进行了调查。比较各研究组按年龄分层的HSIL和宫颈癌发病率。结果:感染多种HPV亚型的女性占研究人群的24.9%。正常细胞学、非典型腺细胞、低级别鳞状上皮内病变(LSIL)、非典型鳞状细胞、不能排除HSIL和HSIL的多型HPV感染率分别为28.2%、26.8%、19.3%、22.6%和21.8%。30岁以下、30-49岁和≥50岁年龄组多型HPV感染率分别为27.8%、24.1%和27.3%。LSIL、HSIL和肿瘤患者多型HPV感染率分别为31.4%、19%和12.5%。结论:多型HPV感染在HSIL和肿瘤患者中的发生率低于单型HPV感染。然而,在老年HSIL和宫颈癌患者中,多型感染率显著。
{"title":"The histologic results in multiple-type HPV infections.","authors":"Sevgi Koç, Dilek Yüksel, Eylem Ünlübilgin, Tuğba Kınay, Fulya Kayıkçıoğlu","doi":"10.4274/jtgga.galenos.2025.2023-4-2","DOIUrl":"10.4274/jtgga.galenos.2025.2023-4-2","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the rate, cytology and histopathological findings of multiple-type human papillomavirus (HPV) positive women referred to a tertiary colposcopy center. To compare the role of multiple- and single-type HPV infections in women with high-grade squamous intra epithelial lesion and cervical cancer (HSIL+).</p><p><strong>Material and methods: </strong>The cytological and histopathological results of 2070 HPV positive women were evaluated. Infection with more than one type was defined as multiple-type HPV infection. Patients were divided into single or multiple HPV groups and subgroups in terms of HPV types; and also examined in three age groups. Age-stratified HSIL and cervical cancer rates of the study groups were compared.</p><p><strong>Results: </strong>The women with multiple HPV subtypes accounted for 24.9% of the study population. Multiple-type HPV infection rates in normal cytology, atypical glandular cells, low-grade squamous intraepithelial lesion (LSIL), atypical squamous cells, cannot exclude HSIL and HSIL were 28.2%, 26.8%, 19.3%, 22.6%, and 21.8%, respectively. Age stratified multiple-type HPV infection rates in under 30 years, 30-49 years and ≥50 years were 27.8%, 24.1%, and 27.3%, respectively. The multiple-type HPV infection rates in LSIL, HSIL, and cancer patients were 31.4%, 19%, and 12.5%, respectively.</p><p><strong>Conclusion: </strong>Multiple-type HPV infections were statistically less common in HSIL and cancer patients than single type HPV infection. However, multiple type infection rates were remarkable in older HSIL and cervical cancer patients.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"90-97"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152812/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266495","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
What is your diagnosis? 你的诊断是什么?
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2024-7-10
Avantika Gupta, Manpreet Kaur, Karanpreet Kaur Bakshi, Erukkambattu Jayashankar
{"title":"What is your diagnosis?","authors":"Avantika Gupta, Manpreet Kaur, Karanpreet Kaur Bakshi, Erukkambattu Jayashankar","doi":"10.4274/jtgga.galenos.2025.2024-7-10","DOIUrl":"10.4274/jtgga.galenos.2025.2024-7-10","url":null,"abstract":"","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"154-156"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152811/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266496","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
In-depth analysis of the demographic landscape and clinical outcomes of assisted reproductive technologies in Türkiye: a comprehensive survey for the years 2020 and 2021. 深入分析日本辅助生殖技术的人口结构和临床结果:2020年和2021年的综合调查。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2025-2-1
Can Benlioğlu, Yunus Aydın, Mehmet Sühha Bostancı, Gürkan Bozdağ, Sibel Bulgurcuoğlu, Ahmet Demir, Serdar Dilbaz, Enver Kerem Dirican, Ahmet Erdem, Elif Ergin, Hale Göksever Çelik, İsmail Güler, Ali Sami Gürbüz, Mete Işıkoğlu, Semra Kahraman, Sezcan Mumuşoğlu, Kemal Özgür, Erhan Şimşek, Yavuz Emre Şükür, Volkan Turan, Gürkan Uncu, Bülent Urman, Evrim Ünsal, Başak Balaban, Barış Ata

Objective: To investigate patient characteristics and outcomes of assisted reproductive technology (ART) cycles conducted in Türkiye during the coronavirus disease-2019 (COVID-19) pandemic (2020-2021).

Material and methods: ART centers in Türkiye were invited to participate in this survey. The questionnaire focused on patient demographics and performance outcomes and was sent to center directors via anonymous Qualtrics™ links.

Results: The survey was sent to 167 centers and data were collected from 15 centers in 2020 and 24 centers in 2021. The clinical pregnancy rate from intrauterine insemination (IUI) procedures remained similar, with 15.1% in 2020 (1,245 IUI cycles) and 14.5% in 2021 (2,023 IUI cycles), while successful delivery rates were 12.5% and 11.5%, respectively. For ART treatments, the clinical pregnancy rate from fresh embryo transfers increased from 45.1% in 2020 (3,119 transfers) to 50.4% in 2021 (8832 transfers), with similar live birth rates, 34.2% vs. 34.4%. Frozen embryo transfers resulted in clinical pregnancy rates of 47.8% in 2020 (2,498 transfers) and 51.9% in 2021 (12,015 transfers), with live birth rates rising from 39.8% to 42.7%. Preimplantation genetic testing cycles resulted in clinical pregnancy rates of 64.2% in 2020 (271 transfers) and 60.8% in 2021 (2,102 transfers), with live birth rates of 53.5% and 48.2%, respectively. Regarding techniques for fertility preservation in females, 11 prepubertal and 61 postpubertal ovarian tissue cryopreservation procedures were reported, alongside 1,346 cycles performed within the same period. In males, 144 post-pubertal testicular tissue, 871 epididymal and 2,480 ejaculated sperm cryopreservations were reported. During the two years, six ovarian tissue transplantations followed by ART were performed, with 96 women using cryopreserved oocytes. In addition, 40 testicular tissue, 298 epididymal, and 238 ejaculated sperm samples were used for ART purposes.

Conclusion: This survey provides a comprehensive overview of ART practices in Türkiye for 2020 and 2021, establishing a long-term, nationallevel analysis while highlighting the challenges posed by the COVID-19 pandemic. The longitudinal analysis established a foundation for future annual reports and offers critical insights into emerging trends over these two years.

目的:探讨2019冠状病毒病(COVID-19)大流行(2020-2021)期间在基耶岛进行辅助生殖技术(ART)周期的患者特征和结果。材料与方法:邀请日本基耶市ART中心参与本调查。问卷主要关注患者的人口统计数据和表现结果,并通过匿名Qualtrics™链接发送给中心主任。结果:共向167个中心发送调查问卷,2020年收集15个中心的数据,2021年收集24个中心的数据。宫内人工授精(IUI)手术的临床妊娠率保持相似,2020年为15.1%(1245个IUI周期),2021年为14.5%(2023个IUI周期),而成功分娩率分别为12.5%和11.5%。对于ART治疗,新鲜胚胎移植的临床妊娠率从2020年的45.1%(3119例移植)增加到2021年的50.4%(8832例移植),活产率相似,分别为34.2%和34.4%。冷冻胚胎移植的临床妊娠率在2020年为47.8%(2498例移植),在2021年为51.9%(12015例移植),活产率从39.8%上升到42.7%。植入前基因检测周期导致2020年临床妊娠率为64.2%(271例转移),2021年为60.8%(2102例转移),活产率分别为53.5%和48.2%。关于保存女性生育能力的技术,报告了11例青春期前和61例青春期后卵巢组织冷冻保存手术,同期进行了1346例周期手术。在男性中,报告了144例青春期后睾丸组织,871例附睾和2480例射精精子冷冻保存。在两年中,进行了6次卵巢组织移植,随后进行了ART,其中96名妇女使用冷冻保存的卵母细胞。此外,40个睾丸组织,298个附睾和238个射精精子样本被用于ART目的。结论:本调查全面概述了日本2020年和2021年的抗逆转录病毒治疗做法,建立了国家层面的长期分析,同时强调了2019冠状病毒病大流行带来的挑战。纵向分析为未来的年度报告奠定了基础,并提供了对这两年新兴趋势的重要见解。
{"title":"In-depth analysis of the demographic landscape and clinical outcomes of assisted reproductive technologies in Türkiye: a comprehensive survey for the years 2020 and 2021.","authors":"Can Benlioğlu, Yunus Aydın, Mehmet Sühha Bostancı, Gürkan Bozdağ, Sibel Bulgurcuoğlu, Ahmet Demir, Serdar Dilbaz, Enver Kerem Dirican, Ahmet Erdem, Elif Ergin, Hale Göksever Çelik, İsmail Güler, Ali Sami Gürbüz, Mete Işıkoğlu, Semra Kahraman, Sezcan Mumuşoğlu, Kemal Özgür, Erhan Şimşek, Yavuz Emre Şükür, Volkan Turan, Gürkan Uncu, Bülent Urman, Evrim Ünsal, Başak Balaban, Barış Ata","doi":"10.4274/jtgga.galenos.2025.2025-2-1","DOIUrl":"10.4274/jtgga.galenos.2025.2025-2-1","url":null,"abstract":"<p><strong>Objective: </strong>To investigate patient characteristics and outcomes of assisted reproductive technology (ART) cycles conducted in Türkiye during the coronavirus disease-2019 (COVID-19) pandemic (2020-2021).</p><p><strong>Material and methods: </strong>ART centers in Türkiye were invited to participate in this survey. The questionnaire focused on patient demographics and performance outcomes and was sent to center directors via anonymous Qualtrics™ links.</p><p><strong>Results: </strong>The survey was sent to 167 centers and data were collected from 15 centers in 2020 and 24 centers in 2021. The clinical pregnancy rate from intrauterine insemination (IUI) procedures remained similar, with 15.1% in 2020 (1,245 IUI cycles) and 14.5% in 2021 (2,023 IUI cycles), while successful delivery rates were 12.5% and 11.5%, respectively. For ART treatments, the clinical pregnancy rate from fresh embryo transfers increased from 45.1% in 2020 (3,119 transfers) to 50.4% in 2021 (8832 transfers), with similar live birth rates, 34.2% vs. 34.4%. Frozen embryo transfers resulted in clinical pregnancy rates of 47.8% in 2020 (2,498 transfers) and 51.9% in 2021 (12,015 transfers), with live birth rates rising from 39.8% to 42.7%. Preimplantation genetic testing cycles resulted in clinical pregnancy rates of 64.2% in 2020 (271 transfers) and 60.8% in 2021 (2,102 transfers), with live birth rates of 53.5% and 48.2%, respectively. Regarding techniques for fertility preservation in females, 11 prepubertal and 61 postpubertal ovarian tissue cryopreservation procedures were reported, alongside 1,346 cycles performed within the same period. In males, 144 post-pubertal testicular tissue, 871 epididymal and 2,480 ejaculated sperm cryopreservations were reported. During the two years, six ovarian tissue transplantations followed by ART were performed, with 96 women using cryopreserved oocytes. In addition, 40 testicular tissue, 298 epididymal, and 238 ejaculated sperm samples were used for ART purposes.</p><p><strong>Conclusion: </strong>This survey provides a comprehensive overview of ART practices in Türkiye for 2020 and 2021, establishing a long-term, nationallevel analysis while highlighting the challenges posed by the COVID-19 pandemic. The longitudinal analysis established a foundation for future annual reports and offers critical insights into emerging trends over these two years.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"109-115"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152775/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of the efficacy of mini-sling in the treatment of stress urinary incontinence through patient-reported outcomes and transperineal ultrasonography. 通过患者报告的结果和经会阴超声检查评价迷你吊带治疗压力性尿失禁的疗效。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2024-8-7
Esra Ayanoğlu, Arzu Bilge Tekin, Murat Yassa, Kemal Sandal, Osman Samet Günkaya, Niyazi Tuğ

Objective: Single-incision slings, such as Contasure-Needleless® (C-NDL), were developed to improve surgical treatment success in stress urinary incontinence (SUI). However, more evidence is needed to describe the outcomes of mini-sling procedures as an alternative to classical mid-urethral slings. The aim was to evaluate the short-term outcomes of the mini-sling procedure using C-NDL in the surgical treatment of SUI patients.

Material and methods: This was a single-center, prospective study including 24 patients with SUI who underwent C-NDL. Michigan Incontinence Severity Index (M-ISI) questionnaire, the Female Sexual Function Index, and the Patient Global Impression of Improvement (PGI-I) questionnaire were applied, as well as trans-perineal ultrasound evaluations at baseline, one month and six months postoperatively.

Results: The PGI-I index showed that 54.17% of participants described their post-operative recovery as "very much better" and 29.17% as "much better". Significant improvements were observed in all SUI and M-ISI-related results. No significant differences were detected in terms of FSFI. Complications were reported as de novo urgency in 4 (16.67%) patients, mesh erosion in 2 (8.33%) patients, and pelvic pain and infection in 1 patient each (4.17%). The mean distance of the mini-sling mesh to the urethra was found to be 5.51±2.3 mm at one month and 4.69±1.85 mm at six months after surgery (p=0.006). The mean urethral rotation angle was decreased following surgery (p<0.001). No significant differences were observed between patients with and without cure regarding any of the examined variables.

Conclusion: For SUI treatment, the C-NDL procedure is a safe and effective method with few complications and high subjective cure rates on short-term follow-up (6 months).

目的:开发contasure - needeless®(C-NDL)等单切口吊带,以提高压力性尿失禁(SUI)的手术治疗成功率。然而,需要更多的证据来描述迷你吊带作为传统尿道中吊带的替代方法的结果。目的是评估使用C-NDL的迷你吊带手术治疗SUI患者的短期效果。材料和方法:这是一项单中心前瞻性研究,包括24例接受C-NDL的SUI患者。应用密歇根失禁严重程度指数(M-ISI)问卷、女性性功能指数和患者整体改善印象(PGI-I)问卷,并在基线、术后1个月和6个月进行经会阴超声评估。结果:PGI-I指数显示54.17%的患者认为术后恢复“非常好”,29.17%的患者认为术后恢复“非常好”。所有SUI和m - i相关结果均有显著改善。在FSFI方面没有发现显著差异。并发症包括:新发急症4例(16.67%),补片糜烂2例(8.33%),盆腔疼痛和感染各1例(4.17%)。术后1个月与尿道的平均距离为5.51±2.3 mm, 6个月与尿道的平均距离为4.69±1.85 mm (p=0.006)。结论:经短期随访(6个月),C-NDL术治疗SUI安全有效,并发症少,主观治愈率高。
{"title":"Evaluation of the efficacy of mini-sling in the treatment of stress urinary incontinence through patient-reported outcomes and transperineal ultrasonography.","authors":"Esra Ayanoğlu, Arzu Bilge Tekin, Murat Yassa, Kemal Sandal, Osman Samet Günkaya, Niyazi Tuğ","doi":"10.4274/jtgga.galenos.2025.2024-8-7","DOIUrl":"10.4274/jtgga.galenos.2025.2024-8-7","url":null,"abstract":"<p><strong>Objective: </strong>Single-incision slings, such as Contasure-Needleless® (C-NDL), were developed to improve surgical treatment success in stress urinary incontinence (SUI). However, more evidence is needed to describe the outcomes of mini-sling procedures as an alternative to classical mid-urethral slings. The aim was to evaluate the short-term outcomes of the mini-sling procedure using C-NDL in the surgical treatment of SUI patients.</p><p><strong>Material and methods: </strong>This was a single-center, prospective study including 24 patients with SUI who underwent C-NDL. Michigan Incontinence Severity Index (M-ISI) questionnaire, the Female Sexual Function Index, and the Patient Global Impression of Improvement (PGI-I) questionnaire were applied, as well as trans-perineal ultrasound evaluations at baseline, one month and six months postoperatively.</p><p><strong>Results: </strong>The PGI-I index showed that 54.17% of participants described their post-operative recovery as \"very much better\" and 29.17% as \"much better\". Significant improvements were observed in all SUI and M-ISI-related results. No significant differences were detected in terms of FSFI. Complications were reported as <i>de novo</i> urgency in 4 (16.67%) patients, mesh erosion in 2 (8.33%) patients, and pelvic pain and infection in 1 patient each (4.17%). The mean distance of the mini-sling mesh to the urethra was found to be 5.51±2.3 mm at one month and 4.69±1.85 mm at six months after surgery (p=0.006). The mean urethral rotation angle was decreased following surgery (p<0.001). No significant differences were observed between patients with and without cure regarding any of the examined variables.</p><p><strong>Conclusion: </strong>For SUI treatment, the C-NDL procedure is a safe and effective method with few complications and high subjective cure rates on short-term follow-up (6 months).</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"98-108"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152813/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266477","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Does geographical location impact the efficacy of oral antihypertensive therapy in pregnancy? 地理位置是否影响妊娠期口服降压药的疗效?
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2024.2024-1-8
Brooke Anderson, Deena Elkafrawi, Cecilia Fochesato, Antonio Schiattarella, Pasquale De Franciscis, Giovanni Sisti

To assess the efficacy of anti-hypertensive medications during pregnancy according to race, ethnicity and geographical location as current evidence is not clear in this regard. A subgroup meta-analysis of randomized controlled trials was performed. The efficacy of oral medications for chronic hypertension in pregnancy by geographical location [United States of America (USA) vs. rest of the World] was investigated. The location was used as a surrogate of racial identification and differences in health care systems and availability of medications that might affect the efficacy of the treatment. The number of patients in each group experiencing the following outcomes: small for gestational age (SGA), preeclampsia, severe hypertension were compared. Seven studies were identified. Subgroup analysis revealed that medications did not affect the occurrence of SGA. In six studies, therapies were protective for preeclampsia in the rest of the world but not in USA (p=0.02). Therapies were protective for severe hypertension. Our findings suggest that location does not affect the efficacy of medication in treating chronic hypertension during pregnancy. Geographical location may serve as a surrogate for genetic characteristics of a population of interest. However, it can also be influenced by other factors such as the heterogeneity of populations such as the USA.

根据种族、民族和地理位置来评估妊娠期间抗高血压药物的疗效,因为目前在这方面的证据还不清楚。对随机对照试验进行亚组荟萃分析。按地理位置对妊娠期慢性高血压口服药物的疗效进行了调查[美利坚合众国(USA)与世界其他地区]。该地点被用作种族识别、医疗保健系统差异和可能影响治疗效果的药物可用性的替代。比较各组出现小胎龄(SGA)、先兆子痫、重度高血压的患者数量。共确定了7项研究。亚组分析显示药物对SGA的发生没有影响。在六项研究中,治疗在世界其他地区对先兆子痫有保护作用,但在美国没有(p=0.02)。治疗对严重高血压有保护作用。我们的研究结果表明,位置不影响药物治疗妊娠期慢性高血压的疗效。地理位置可以代替感兴趣的群体的遗传特征。然而,它也可能受到其他因素的影响,如美国等人口的异质性。
{"title":"Does geographical location impact the efficacy of oral antihypertensive therapy in pregnancy?","authors":"Brooke Anderson, Deena Elkafrawi, Cecilia Fochesato, Antonio Schiattarella, Pasquale De Franciscis, Giovanni Sisti","doi":"10.4274/jtgga.galenos.2024.2024-1-8","DOIUrl":"10.4274/jtgga.galenos.2024.2024-1-8","url":null,"abstract":"<p><p>To assess the efficacy of anti-hypertensive medications during pregnancy according to race, ethnicity and geographical location as current evidence is not clear in this regard. A subgroup meta-analysis of randomized controlled trials was performed. The efficacy of oral medications for chronic hypertension in pregnancy by geographical location [United States of America (USA) vs. rest of the World] was investigated. The location was used as a surrogate of racial identification and differences in health care systems and availability of medications that might affect the efficacy of the treatment. The number of patients in each group experiencing the following outcomes: small for gestational age (SGA), preeclampsia, severe hypertension were compared. Seven studies were identified. Subgroup analysis revealed that medications did not affect the occurrence of SGA. In six studies, therapies were protective for preeclampsia in the rest of the world but not in USA (p=0.02). Therapies were protective for severe hypertension. Our findings suggest that location does not affect the efficacy of medication in treating chronic hypertension during pregnancy. Geographical location may serve as a surrogate for genetic characteristics of a population of interest. However, it can also be influenced by other factors such as the heterogeneity of populations such as the USA.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"142-153"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152777/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266476","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Çepni modification: using bilateral vascular clamps during caesarean section for intrapartum hemorrhage, a randomized controlled trial. Çepni修改:在剖宫产术中使用双侧血管夹治疗产内出血,一项随机对照试验。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2024-10-4
İsmail Çepni, Kübra Hamzaoğlu Canbolat, İpek Betül Özçivit Erkan, Uğurcan Sayılı, Bahar Yüksel Özgör, Elifnur Özak, Aytaç Mahmudova, Rıza Madazlı, Kutsiye Pelin Öcal

Objective: Our aim was to reduce blood loss during C-section through the intraoperative temporary occlusion of the bilateral uterine vascular bundles.

Material and methods: This randomized controlled study included 99 singleton pregnant patients at 37 weeks of gestation or later, with normal fetal development and no obstetric complications, attending a university hospital. In the intervention group (n=45), bilateral occlusion of the uterine vascular bundles at their entry point to the uterus was performed using atraumatic Darmklemmen clamps after the delivery of the baby. In the control group (n=54), routine C-section was performed. Our primary outcome was the amount of blood loss, measured using the suction canister, gauze and abdominal mops and underpads after the operation, along with the comparison of preoperative and postoperative hemoglobin and hematocrit values. Our secondary outcomes were operative time, transfusion rate, maternal outcomes (including postoperative complications during follow-up), and neonatal outcomes.

Results: In the intervention group, blood loss measured in gauze, abdominal compress pads, underpads and total blood loss were significantly lower than in the control group (p=0.031, p=0.001, p=0.003, and p=0.010, respectively). The mean decrease in hematocrit value was 5.3±2.67% in the intervention group and 4.85±2.53% in the control group (p>0.05). Operative time and neonatal outcomes were similar between the two groups. No perioperative or postoperative complications were observed during follow-up.

Conclusion: Bilateral temporary occlusion of the uterine vascular bundles using atraumatic clamps was a feasible and safe technique for reducing blood loss during cesarean section without adverse maternal and neonatal outcomes. Trial registration number and date of registration: NCT05948436- July 10, 2023.

目的:通过术中暂时阻断双侧子宫血管束,减少剖宫产时的出血量。材料和方法:这项随机对照研究包括99例妊娠37周或更晚、胎儿发育正常且无产科并发症的单胎妊娠患者,在一所大学医院就诊。在干预组(n=45)中,在婴儿分娩后,使用无伤性Darmklemmen钳在子宫入口处双侧闭塞子宫血管束。对照组(n=54)行常规剖腹产。我们的主要结果是术后用吸盘、纱布、腹部拖地和垫测量的出血量,以及术前和术后血红蛋白和红细胞压积值的比较。次要结局是手术时间、输血率、产妇结局(包括随访期间的术后并发症)和新生儿结局。结果:干预组纱布、腹部压垫、衬垫出血量及总出血量均显著低于对照组(p=0.031、p=0.001、p=0.003、p=0.010)。干预组红细胞压积值平均下降5.3±2.67%,对照组平均下降4.85±2.53% (p < 0.05)。两组手术时间和新生儿结局相似。随访期间无围手术期及术后并发症。结论:无伤性钳夹双侧子宫血管束暂时闭塞术是一种安全可行的技术,可减少剖宫产术中出血量,无不良母婴结局。试验注册号及注册日期:NCT05948436- 2023年7月10日。
{"title":"The Çepni modification: using bilateral vascular clamps during caesarean section for intrapartum hemorrhage, a randomized controlled trial.","authors":"İsmail Çepni, Kübra Hamzaoğlu Canbolat, İpek Betül Özçivit Erkan, Uğurcan Sayılı, Bahar Yüksel Özgör, Elifnur Özak, Aytaç Mahmudova, Rıza Madazlı, Kutsiye Pelin Öcal","doi":"10.4274/jtgga.galenos.2025.2024-10-4","DOIUrl":"10.4274/jtgga.galenos.2025.2024-10-4","url":null,"abstract":"<p><strong>Objective: </strong>Our aim was to reduce blood loss during C-section through the intraoperative temporary occlusion of the bilateral uterine vascular bundles.</p><p><strong>Material and methods: </strong>This randomized controlled study included 99 singleton pregnant patients at 37 weeks of gestation or later, with normal fetal development and no obstetric complications, attending a university hospital. In the intervention group (n=45), bilateral occlusion of the uterine vascular bundles at their entry point to the uterus was performed using atraumatic Darmklemmen clamps after the delivery of the baby. In the control group (n=54), routine C-section was performed. Our primary outcome was the amount of blood loss, measured using the suction canister, gauze and abdominal mops and underpads after the operation, along with the comparison of preoperative and postoperative hemoglobin and hematocrit values. Our secondary outcomes were operative time, transfusion rate, maternal outcomes (including postoperative complications during follow-up), and neonatal outcomes.</p><p><strong>Results: </strong>In the intervention group, blood loss measured in gauze, abdominal compress pads, underpads and total blood loss were significantly lower than in the control group (p=0.031, p=0.001, p=0.003, and p=0.010, respectively). The mean decrease in hematocrit value was 5.3±2.67% in the intervention group and 4.85±2.53% in the control group (p>0.05). Operative time and neonatal outcomes were similar between the two groups. No perioperative or postoperative complications were observed during follow-up.</p><p><strong>Conclusion: </strong>Bilateral temporary occlusion of the uterine vascular bundles using atraumatic clamps was a feasible and safe technique for reducing blood loss during cesarean section without adverse maternal and neonatal outcomes. Trial registration number and date of registration: NCT05948436- July 10, 2023.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"73-81"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152814/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Predictive efficacy of rectus abdominis muscle and psoas major muscle thickness for postoperative morbidity in patients with endometrial cancer. 腹直肌和腰大肌厚度对子宫内膜癌患者术后发病率的预测作用。
IF 1.2 Q3 OBSTETRICS & GYNECOLOGY Pub Date : 2025-06-10 DOI: 10.4274/jtgga.galenos.2025.2025-4-6
Hasan Burak Rastgeldi, Tufan Arslanca, Halitcan Batur, Okan Aytekin, Abdurrahman Alp Tokalıoğlu, Fatih Kılıç, Taner Turan

Objective: The association between skeletal muscle mass and postoperative morbidity in cancer patients has been demonstrated, but the results are not conclusive. The study aims to determine the predictive efficacy of rectus abdominis muscle (RAM) and psoas major muscle (PMM) thickness and other factors such as age, American Society of Anesthesiologists (ASA) score, operation duration, obesity, preoperative inflammatory markers, and pathological findings for postoperative morbidity.

Material and methods: One hundred forty-one patients who underwent total abdominal hysterectomy + bilateral salpingo-oophorectomy + retroperitoneal lymphadenectomy + omentectomy for endometrial cancer were assessed retrospectively. Standard procedures (antibiotic prophylaxis and thromboembolism prophylaxis) were applied pre- and postoperatively, and the thicknesses of the RAM and PMM were measured by computed tomography. Postoperative morbidity was defined in the 3-month postoperative period as patients treated with a diagnosis of postoperative infection, those who developed pulmonary complications, thromboembolic complications, lymphatic drainage disorders, intracranial hemorrhage, and mortality.

Results: The mean thickness of the right-left RAM in the morbidity group was 7.4±2.1 mm, and 8.2±2.1 mm in the group without morbidity (p=0.038). On the other hand, the thickness of the right-left PMM was similar in both groups. When the predictive cut-off value for RAM thickness was 7.52 mm, the sensitivity, specificity, and negative and positive predictive values were 54.2%, 65.6%, 73.5%, and 44.8%, respectively. Advanced age, high ASA score, and extended operation duration were associated with an increased risk of morbidity in univariate analysis. However, multivariate analysis revealed that only age and operation duration were independent risk factors for postoperative morbidity [respectively, odds ratio (OR): 1.06, 95% confidence interval (CI): 1.01-1.12, p=0.033 and OR: 1.003, 95% CI: 1.0003-1.007, p=0.039].

Conclusion: Age and operation duration were identified as independent risk factors for predicting postoperative morbidity. However, it has been shown that a more comprehensive evaluation, including RAM thickness and ASA score alongside these two factors, could provide more definitive results.

目的:骨骼肌质量与癌症患者术后发病率之间的关系已得到证实,但结果尚无定论。本研究旨在确定腹直肌(RAM)和腰肌大肌(PMM)厚度以及年龄、美国麻醉医师学会(ASA)评分、手术持续时间、肥胖、术前炎症标志物、病理结果等因素对术后发病率的预测作用。材料与方法:回顾性分析141例子宫内膜癌患者行腹式全子宫切除术+双侧输卵管-卵巢切除术+腹膜后淋巴结切除术+网膜切除术。术前和术后应用标准程序(抗生素预防和血栓栓塞预防),并通过计算机断层扫描测量RAM和PMM的厚度。术后发病率定义为术后3个月内诊断为术后感染、出现肺部并发症、血栓栓塞性并发症、淋巴引流障碍、颅内出血和死亡率的患者。结果:发病组左右RAM平均厚度为7.4±2.1 mm,无发病组平均厚度为8.2±2.1 mm (p=0.038)。另一方面,两组的左右PMM厚度相似。当RAM厚度预测临界值为7.52 mm时,敏感性为54.2%,特异性为65.6%,阴性预测值为73.5%,阳性预测值为44.8%。单因素分析显示,高龄、ASA评分高、手术时间延长与发病风险增加相关。然而,多因素分析显示,只有年龄和手术时间是术后发病率的独立危险因素[比值比(OR): 1.06, 95%可信区间(CI): 1.01-1.12, p=0.033; OR: 1.003, 95% CI: 1.0003-1.007, p=0.039]。结论:年龄和手术时间是预测术后发病率的独立危险因素。然而,研究表明,更全面的评估,包括RAM厚度和ASA评分以及这两个因素,可以提供更明确的结果。
{"title":"Predictive efficacy of rectus abdominis muscle and psoas major muscle thickness for postoperative morbidity in patients with endometrial cancer.","authors":"Hasan Burak Rastgeldi, Tufan Arslanca, Halitcan Batur, Okan Aytekin, Abdurrahman Alp Tokalıoğlu, Fatih Kılıç, Taner Turan","doi":"10.4274/jtgga.galenos.2025.2025-4-6","DOIUrl":"10.4274/jtgga.galenos.2025.2025-4-6","url":null,"abstract":"<p><strong>Objective: </strong>The association between skeletal muscle mass and postoperative morbidity in cancer patients has been demonstrated, but the results are not conclusive. The study aims to determine the predictive efficacy of rectus abdominis muscle (RAM) and psoas major muscle (PMM) thickness and other factors such as age, American Society of Anesthesiologists (ASA) score, operation duration, obesity, preoperative inflammatory markers, and pathological findings for postoperative morbidity.</p><p><strong>Material and methods: </strong>One hundred forty-one patients who underwent total abdominal hysterectomy + bilateral salpingo-oophorectomy + retroperitoneal lymphadenectomy + omentectomy for endometrial cancer were assessed retrospectively. Standard procedures (antibiotic prophylaxis and thromboembolism prophylaxis) were applied pre- and postoperatively, and the thicknesses of the RAM and PMM were measured by computed tomography. Postoperative morbidity was defined in the 3-month postoperative period as patients treated with a diagnosis of postoperative infection, those who developed pulmonary complications, thromboembolic complications, lymphatic drainage disorders, intracranial hemorrhage, and mortality.</p><p><strong>Results: </strong>The mean thickness of the right-left RAM in the morbidity group was 7.4±2.1 mm, and 8.2±2.1 mm in the group without morbidity (p=0.038). On the other hand, the thickness of the right-left PMM was similar in both groups. When the predictive cut-off value for RAM thickness was 7.52 mm, the sensitivity, specificity, and negative and positive predictive values were 54.2%, 65.6%, 73.5%, and 44.8%, respectively. Advanced age, high ASA score, and extended operation duration were associated with an increased risk of morbidity in univariate analysis. However, multivariate analysis revealed that only age and operation duration were independent risk factors for postoperative morbidity [respectively, odds ratio (OR): 1.06, 95% confidence interval (CI): 1.01-1.12, p=0.033 and OR: 1.003, 95% CI: 1.0003-1.007, p=0.039].</p><p><strong>Conclusion: </strong>Age and operation duration were identified as independent risk factors for predicting postoperative morbidity. However, it has been shown that a more comprehensive evaluation, including RAM thickness and ASA score alongside these two factors, could provide more definitive results.</p>","PeriodicalId":17440,"journal":{"name":"Journal of the Turkish German Gynecological Association","volume":"26 2","pages":"121-129"},"PeriodicalIF":1.2,"publicationDate":"2025-06-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12152816/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144266480","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of the Turkish German Gynecological Association
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1